Showing 15 posts of 141 posts found.

Travellers with Indian-made AZ jab may face European ban

July 2, 2021
Medical Communications COVID-19, India, Vaccine

Up to 5 million Britons planning to travel to Europe may face a travel ban if they have been vaccinated …

India report record number of COVID deaths as bodies drift down Ganges

May 12, 2021
Research and Development COVID-19, India, Indian COVID crisis, covid 19 news, covid-19 news, pharma, pharma news

India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.

Bharat Biotech jab shows 100% efficacy against severe COVID-19

April 22, 2021
COVID-19, India

Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, …


India signs deal for 100m doses of Russia’s Sputnik V COVID-19 vaccine

September 16, 2020
Manufacturing and Production, Research and Development COVID-19, India, Russia, Vaccine

Russia has signed a deal with an Indian pharma firm to test and deliver 100 million doses of its controversial …


Amazon Pharmacy launches in India

August 17, 2020
Sales and Marketing India, amazon, pharma

Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India. 


Novavax inks deal to deliver one billion COVID-19 vaccine doses in India and other regions

August 10, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, India, Novavax, Serum Institute of India Private Limited, Vaccine

Novavax is partnering up with the Serum Institute of India Private Limited (SIIPL) in a licensing deal to development and …


India’s National Task Force rejects Biocon’s itolizumab for COVID-19

July 27, 2020
Sales and Marketing Biocon, COVID-19, India, Itolizumab

Biocon was hit with bad news over the weekend as the National Task Force for COVID-19 in its home country …


Mylan launches generic version of Gilead’s remdesivir for COVID-19 patients in India

July 20, 2020
Sales and Marketing COVID-19, Gilead, India, Mylan, generic, remdesivir

Mylan has launched its own generic version of Gilead’s remdesivir on the Indian market for the treatment of patients with …


India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19

June 3, 2020
Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …


Indian regulators approve first drug for patients with NASH

March 6, 2020
Medical Communications FDA Approval, India, Indian Pharma, drug approval

The Drug Controller General of India (DCGI) has approved the marketing application for Zydus Cadila’s saroglitazar to treat patients with …


Study shows widespread bribery in Indian pharmaceutical industry

November 29, 2019
Medical Communications India, Indian Pharma, Modi, bribery

A recent report by the Support for Advocacy and Training to Health Initiatives (Sathi) revealed the widespread use of bribes …


Over half of all US/EU regulator warnings issued to Indian and Chinese manufacturers, report finds

August 28, 2019
Manufacturing and Production, Research and Development China, India, MHRA, UK, manufacturing, pharma

Concerns have been raised concerning the integrity of the global supply chain after a report from The Pharmaceutical Journal revealed …


Three workers killed by explosion at pharma factory in India

June 11, 2019
Manufacturing and Production China, India, explosion, manufacturing, pharma

Three engineers have been killed in an explosion at a manufacturing facility in India. Two Chinese engineers and one Indian …


Children born in poverty show major differences in brain function, study shows

April 3, 2019
Research and Development India, UEA, brain development, brain function, childhood, children

Children born into poverty show major differences in early brain function, according to research from the University of East Anglia. …

Latest content